BioSpace News Archive

Business

Statement from Mylan’s Board of Directors

Global pharmaceutical company Mylan N.V.'sboard of directors today released the following statement

August 8, 2018
·
5 min read
Policy

Corporate Whistleblower Center Appeals to Physicians With Proof a Healthcare Service Provider Is Bribing Medical Doctors for Patients to Call About Potentially Substantial Rewards

According to the Corporate Whistleblower Center, “We are urging a medical doctor or a physician practice manager with proof any kind of healthcare service provider is paying kickbacks to medical doctors for new clients to call us anytime at 866-714-6466.

August 8, 2018
·
3 min read
Deals

STAAR Surgical Announces Pricing of Public Offering of 1,739,000 shares Of Its Common Stock

STAAR Surgical Company announced the pricing of the previously announced underwritten public offering of 1,739,000 shares of its common stock

August 8, 2018
·
4 min read
Biotech Beach

Affordable Regenerative Stem Cell Therapy is Now Offered Through Zen Care Physical Medicine in Irvine at an Extraordinary Value

Dr. Jay Kang, clinical director of Zen Care Physical Medicine has introduced Regenerative Stem Cell Therapy at his Irvine, CA office to help his patients overcome certain debilitating injuries.

August 8, 2018
·
1 min read
Business

TimiHealth Program Empowering Consumers to Profit from their DNA Data Will Be Listed on LATOKEN Where Trading Starts Aug. 9, Part of a Two Million Timicoin Giveaway

Timicoin/TimiHealth (www.timicoin.io),the first operating blockchain designed to empower individuals through itsTimiDNA platform to own, control, and monetize their genetic DNA data,will also be the first to actually pay them for it via LATOKEN (www.LATOKEN.COM).

August 8, 2018
·
2 min read
Deals

BioStem Technologies Inc. Launches Expanded Shareholder Communications Initiative

BioStem Technologies, Inc. has announced that it has implemented an expanded shareholder communications initiative to provide improved clarity into BioStem’s business plans, upcoming research and development, drug approvals and growth strategy.

August 8, 2018
·
3 min read
Business

Corbus Pharmaceuticals Reports 2018 Second Quarter Financial Results and Provides Business Update

Lenabasum has reached Phase 3 clinical stage in two orphan autoimmune indications: systemic sclerosis and dermatomyositis, affecting up to 200,000 patients in the USA, EU and Japan

August 8, 2018
·
17 min read
BioMidwest

Bio-Techne Introduces GMP Small Molecules for Stem Cell Therapy Development

Bio-Techne has introduced a new range of Tocris Bioscience-branded stem cell research compounds produced to cGMP standards, which are suitable for use as ancillary materials in the development of stem cell therapies.

August 8, 2018
·
2 min read
FDA

A First in the World of Radiology: Aidoc Receives FDA Clearance to Enable Radiologists to Triage Patients Using AI

A new era in decision support systems tailor-made for radiologists

August 8, 2018
·
3 min read
Deals

Dual-Listed CollPlant to Voluntarily Delist From Tel Aviv Stock Exchange

CollPlant’s American Depositary Shares to continue trading on the Nasdaq Capital Market

August 8, 2018
·
5 min read